Non-Human Leukocyte Antigen Antibody-Mediated Lung Transplant Rejection: The Other Anti-A

REFERENCES

1. 1.↵
   1. Benzimra M,
   2. Glanville AR

   . Lung transplant rejection and surveillance in 2016: newer options. Curr Transpl Rep. 2016 Jun;3:192-198. doi: 10.1007/s40472-016-0104-y.

   OpenUrlCrossRef
2. 2.↵
   1. Roden AC,
   2. Aisner DL,
   3. Allen TC,
   4. et al.

   Diagnosis of acute cellular rejection and antibody-mediated rejection on lung transplant biopsies: a perspective from members of the pulmonary pathology society. Arch Pathol Lab Med. 2017 Mar;141(3):437-444. doi: 10.5858/arpa.2016-0459-SA.

   OpenUrlCrossRef
3. 3.↵
   1. Levine DJ,
   2. Glanville AR,
   3. Aboyoun C,
   4. et al.

   Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2016 Apr;35(4):397-406. doi: 10.1016/j.healun.2016.01.1223.

   OpenUrlCrossRef
4. 4.↵
   1. Wallace WD,
   2. Li N,
   3. Andersen CB,
   4. et al.

   Banff study of pathologic changes in lung allograft biopsy specimens with donor-specific antibodies. J Heart Lung Transplant. 2016 Jan;35(1):40-48. doi: 10.1016/j.healun.2015.08.021.

   OpenUrlCrossRef
5. 5.↵
   1. Hosoi E

   . Biological and clinical aspects of ABO blood group system. J Med Invest. 2008 Aug;55(3-4):174-182.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Storry JR,
   2. Olsson ML

   . The ABO blood group system revisited: a review and update. Immunohematology. 2009;25(2):48-59.

   OpenUrlPubMedWeb of Science
7. 7.↵
   1. Fadeyi EA,
   2. Stratta RJ,
   3. Farney AC,
   4. Pomper GJ

   . Successful ABO-incompatible renal transplantation: blood group A1B donor into A2B recipient with anti-A1 isoagglutinins. Am J Clin Pathol. 2016 Aug;146(2):268-271. doi: 10.1093/ajcp/aqw101.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Campos S,
   2. Caramori M,
   3. Teixeira R,
   4. et al.

   Bacterial and fungal pneumonias after lung transplantation. Transplant Proc. 2008 Apr;40(3):822-824. doi: 10.1016/j.transproceed.2008.02.049.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Kramer MR,
   2. Marshall SE,
   3. Starnes VA,
   4. Gamberg P,
   5. Amitai Z,
   6. Theodore J

   . Infectious complications in heart-lung transplantation: analysis of 200 episodes. Arch Intern Med. 1993 Sep 13;153(17):2010-2016.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Belkarty B,
    2. Bilton D,
    3. Jones A

    . Serratia marcescens: an emerging pathogen or innocent bystander? J Cyst Fibros. 2015 Jun;14(1);S7260. doi: 10.1016/S1569-1993(15)30237-X.

    OpenUrlCrossRef
11. 11.↵
    1. Lata C,
    2. Parkins M,
    3. Somayaji R,
    4. et al.

    Epidemiology and clinical outcomes of Serratia marcescens infections in adults with cystic fibrosis. Open Forum Infect Dis. 2016 Dec;3(1):1228. doi: 10.1093/ofid/ofw172.931.

    OpenUrlCrossRef